New York State Common Retirement Fund
LGND icon

New York State Common Retirement Fund’s Ligand Pharmaceuticals LGND Stock Holding History

New York State Common Retirement Fund’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.4M Buy
137,258
+17,419
+15% +$4.1M 0.05% 241
2026
Q1 		$23.9M Buy
119,839
+12,309
+11% +$2.44M 0.03% 369
2025
Q4 		$20.3M Buy
107,530
+21,001
+24% +$4.04M 0.03% 428
2025
Q3 		$15.3M Sell
86,529
-13,008
-13% -$1.93M 0.02% 553
2025
Q2 		$11.3M Hold
99,537
– – 0.02% 686
2025
Q1 		$10.5M Buy
99,537
+7,119
+8% +$805K 0.02% 696
2024
Q4 		$9.9M Buy
92,418
+6,123
+7% +$692K 0.01% 787
2024
Q3 		$8.64M Buy
86,295
+78,953
+1,075% +$7.95M 0.01% 857
2024
Q2 		$619K Buy
7,342
+142
+2% +$11.3K ﹤0.01% 1961
2024
Q1 		$526K Hold
7,200
– – ﹤0.01% 2058
2023
Q4 		$514K Sell
7,200
-576
-7% -$34K ﹤0.01% 2086
2023
Q3 		$466K Buy
7,776
+166
+2% +$10.9K ﹤0.01% 2086
2023
Q2 		$549K Sell
7,610
-290
-4% -$21.8K ﹤0.01% 2043
2023
Q1 		$581K Sell
7,900
-2,900
-27% -$206K ﹤0.01% 2101
2022
Q4 		$721K Sell
10,800
-6,732
-38% -$438K ﹤0.01% 2137
2022
Q3 		$942K Buy
17,532
+46
+0.3% +$2.7K ﹤0.01% 2004
2022
Q2 		$973K Sell
17,486
-43
-0.2% -$2.44K ﹤0.01% 2034
2022
Q1 		$1.23M Sell
17,529
-336
-2% -$24.4K ﹤0.01% 1997
2021
Q4 		$1.72M Sell
17,865
-989
-5% -$91.4K ﹤0.01% 1849
2021
Q3 		$1.64M Sell
18,854
-3,280
-15% -$254K ﹤0.01% 1863
2021
Q2 		$1.81M Buy
22,134
+197
+0.9% +$16.4K ﹤0.01% 1928
2021
Q1 		$2.09M Buy
21,937
+617
+3% +$58.3K ﹤0.01% 1758
2020
Q4 		$1.32M Sell
21,320
-6,269
-23% -$357K ﹤0.01% 1901
2020
Q3 		$1.64M Sell
27,589
-10,072
-27% -$687K ﹤0.01% 1674
2020
Q2 		$2.63M Buy
37,661
+11,211
+42% +$711K ﹤0.01% 1423
2020
Q1 		$1.2M Buy
26,450
+1,764
+7% +$100K ﹤0.01% 1648
2019
Q4 		$1.61M Sell
24,686
-6,412
-21% -$428K ﹤0.01% 1719
2019
Q3 		$1.93M Sell
31,098
-37,518
-55% -$2.36M ﹤0.01% 1664
2019
Q2 		$4.89M Sell
68,616
-7,611
-10% -$561K 0.01% 1269
2019
Q1 		$5.98M Buy
76,227
+4,825
+7% +$366K 0.01% 1171
2018
Q4 		$6.04M Sell
71,402
-87
-0.1% -$9.28K 0.01% 1105
2018
Q3 		$12.2M Sell
71,489
-9,259
-11% -$1.4M 0.01% 912
2018
Q2 		$10.4M Sell
80,748
-9,366
-10% -$1.05M 0.01% 991
2018
Q1 		$9.29M Buy
90,114
+21,190
+31% +$2.1M 0.01% 1016
2017
Q4 		$5.89M Buy
68,924
+3,267
+5% +$283K 0.01% 1186
2017
Q3 		$5.58M Sell
65,657
-25,746
-28% -$2.04M 0.01% 1178
2017
Q2 		$6.92M Buy
91,403
+9,042
+11% +$633K 0.01% 1127
2017
Q1 		$5.44M Buy
82,361
+3,580
+5% +$236K 0.01% 1206
2016
Q4 		$4.99M Sell
78,781
-2,829
-3% -$179K 0.01% 1251
2016
Q3 		$5.2M Sell
81,610
-27,849
-25% -$2.04M 0.01% 1212
2016
Q2 		$8.14M Sell
109,459
-14,140
-11% -$1.05M 0.01% 1032
2016
Q1 		$8.26M Buy
123,599
+54,898
+80% +$3.34M 0.01% 984
2015
Q4 		$4.65M Buy
68,701
+11,814
+21% +$729K 0.01% 1259
2015
Q3 		$3.04M Sell
56,887
-28,774
-34% -$1.75M ﹤0.01% 1414
2015
Q2 		$5.39M Sell
85,661
-12,399
-13% -$677K 0.01% 1310
2015
Q1 		$4.72M Buy
98,060
+31,917
+48% +$1.22M 0.01% 1240
2014
Q4 		$2.2M Sell
66,143
-1,603
-2% -$52.1K ﹤0.01% 1592
2014
Q3 		$1.99M Sell
67,746
-31,267
-32% -$1.04M ﹤0.01% 1624
2014
Q2 		$3.85M Buy
99,013
+25,015
+34% +$1.02M 0.01% 1377
2014
Q1 		$3.1M Buy
73,998
+29,915
+68% +$1.25M ﹤0.01% 1446
2013
Q4 		$1.45M Buy
+44,083
New +$1.44M ﹤0.01% 1735

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

New York State Common Retirement Fund's LGND Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Ligand Pharmaceuticals (LGND) stake by 15% in Q2 2026, buying an estimated $4.1M and bringing the position to 137,258 shares worth $43.4M. The position accounts for 0.05% of the portfolio, ranked #241.

New York State Common Retirement Fund first reported a position in LGND in Q4 2013 and has held it in 51 quarters since. 146 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • New York State Common Retirement Fund held 137,258 shares of Ligand Pharmaceuticals worth $43.4M as of Q2 2026.
  • New York State Common Retirement Fund bought 17,419 Ligand Pharmaceuticals shares in Q2 2026, an estimated $4.1M.
  • Ligand Pharmaceuticals made up 0.05% of New York State Common Retirement Fund's portfolio in Q2 2026, its #241 holding.
  • New York State Common Retirement Fund first reported a position in Ligand Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
  • 146 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.